Consult the medical resource doctors trust
UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.
Related articles
![]() | Preview Available (subscription required for full access) |







| AuthorDavid T Yu, MD | Section EditorJoachim Sieper, MD | Deputy EditorsLeah K Moynihan, RNC, MSNPaul L Romain, MD |
Contents of this article
ANKYLOSING SPONDYLITIS OVERVEIW
Ankylosing spondylitis (AS) is a chronic inflammatory disease that causes joint pain in the back, neck, and sometimes the hips. The back is composed of multiple separate bones known as vertebrae. "Ankylosing" means joining together, and refers to an inflexibility between the vertebrae; "spondylitis" means inflammation of the vertebrae.
This topic discusses the symptoms, diagnostic tests, possible complications, and treatment of ankylosing spondylitis. Separate topic reviews are available that discuss some of the medications used to treat ankylosing spondylitis. (See "Patient information: Disease modifying antirheumatic drugs (DMARDs)".) and exercises that can help people with ankylosing spondylitis to stretch and strengthen. (See "Patient information: Arthritis and exercise".)
ANKYLOSING SPONDYLITIS SYMPTOMS
The most common symptom of ankylosing spondylitis is pain in the low back and hips. Pain, stiffness, and limited mobility in other joints also occurs in some patients. More detailed information is available separately. (See "Clinical manifestations of ankylosing spondylitis in adults".)
Spinal pain — Spinal pain, almost always in the low back, is usually the first and most common symptom of ankylosing spondylitis. Back pain that occurs with ankylosing spondylitis generally has some of the following characteristics:
Limited spinal mobility — The flexibility of the back may be reduced. Putting on shoes and stockings may become difficult due to a limited ability to bend forward.
ANKYLOSING SPONDYLITIS RISK FACTORS
Ankylosing spondylitis is three times more common in males than in females. It is usually diagnosed in young adults between age 20 and 30 years.
The disease can be more common in certain families. For example, a person's risk of developing ankylosing spondylitis increases if a first-degree relative (parent, sibling, or child) has ankylosing spondylitis. The presence of a gene called HLA-B27 may also increase the risk of developing ankylosing spondylitis.
ANKYLOSING SPONDYLITIS DIAGNOSIS
The diagnosis of ankylosing spondylitis is based upon a combination of a patient's symptoms, physical examination, and imaging tests. (See "Diagnosis and differential diagnosis of ankylosing spondylitis in adults".)
Imaging tests — People with ankylosing spondylitis develop characteristic changes in the sacroiliac joints (the joint that connects the tailbone [sacrum] and large pelvic bone [ilium]) and spine. These changes can be seen on x-ray images, although the changes take time to develop and may not be apparent until years after ankylosing spondylitis is diagnosed.
Imaging tests such as magnetic resonance imaging (MRI) and computed tomography (CT scanning) are more sensitive than plain x-rays, and may be used if ankylosing spondylitis is suspected but not clearly seen on x-ray.
Other tests — There is no blood test that definitively diagnoses ankylosing spondylitis, although testing for a gene, HLA-B27, can be helpful in selected groups of patients. A negative test for HLA-B27 in a person who is white and of European descent suggests they do not have ankylosing spondylitis.
ANKYLOSING SPONDYLITIS COMPLICATIONS
Complications of ankylosing spondylitis are rare, with the exception of anterior uveitis.
Anterior uveitis — Uveitis, or inflammation of part of the eye, is the most common ankylosing spondylitis-related problem that does not involve joints. Uveitis causes pain in the eye, blurring of vision, and light sensitivity. Uveitis requires immediate medical attention and treatment with eye medications, and generally resolves within two to three months.
Neurologic problems — The bones of the spine cover and protect the spinal cord and spinal nerves. People with ankylosing spondylitis are at an increased risk of spinal cord injury because the fused spine is weaker and more likely to fracture in the event of an accident. Such spinal injuries can cause compression of the spinal cord, which can result in changes in sensation and mobility below the level of compression.
Symptoms of spinal cord compression include a change or loss of sensation in the arms or legs, weakness, or difficulty controlling the bowels or bladder. If you notice any of these symptoms after an injury or accident, even a minor one, you need immediate medical attention to determine if you have a fracture or dislocation. If left untreated, such spinal cord injuries can lead to permanent paralysis.
Cardiovascular disease — Some patients with ankylosing spondylitis have heart problems thought to be related to the disorder. Problems with the heart valves are sometimes seen; the most common problem is a leaking aortic valve (aortic regurgitation).
Pulmonary disease — Many people with ankylosing spondylitis are unable to expand the chest normally during breathing because of stiffness between the ribs and the spine. In some cases, changes in the lungs can result. This may or may not cause breathing problems.
Ulcerations in the bowel — Many people with ankylosing spondylitis will develop ulcerations in the lining of the bowels, although these ulcerations do not usually cause any symptoms.
EFFECTS OF ANKYLOSING SPONDYLITIS ON DAILY LIFE
Ankylosing spondylitis can affect daily life in various ways. Dressing, reaching, rising from a chair, getting up from the floor, standing, climbing steps, looking to the side or over the shoulder, exercising, and doing household or work-related tasks can become more difficult as a result of the limited joint and spinal motion in ankylosing spondylitis. These limitations can affect you and your family, and many people with ankylosing spondylitis will require assistance from family and friends.
ANKYLOSING SPONDYLITIS TREATMENT
Ankylosing spondylitis treatment is tailored for each individual, based on the characteristics and severity of the disease. Treatment may include any of the following. (See "Treatment and prognosis of ankylosing spondylitis in adults".)
Exercise — Exercise should be part of the treatment program for everyone with ankylosing spondylitis. It can include home exercises, individual or group exercise with a physical therapist, or physical therapy treatments (PT). Optimally, each patient should be evaluated and be given instructions by a physical therapist. The exercise should consist of posture training, deep breathing, back extension, and other stretching movements. (See "Patient information: Arthritis and exercise".)
An animated demonstration of exercises designed for people with ankylosing spondylitis is available on the following website: www.nass.co.uk/public/exercises.htm.
Shower or tub grab-bars and night-lights decrease the chance of a fall. Loose rugs increase the risk of tripping and should be removed or carefully attached to the floor with removable adhesive strips or pads. Seat belts reduce the risk of injury in a car crash and should be worn while driving or riding in a vehicle. A wrap-around rear view mirror can improve visibility for drivers who cannot turn their head and neck.
To avoid developing deformities of the neck, a thin, rather than a thick pillow, is recommended for sleeping.
Nonsteroidal antiinflammatory drugs (NSAID) — Almost everyone with active ankylosing spondylitis needs an NSAID to control pain and stiffness. NSAIDs need to be taken on a regular basis for two weeks before their maximum effect can be judged. Doses of NSAIDS are available in table 1 (table 1). (See "Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs)".)
There are a number of over-the-counter and prescription NSAID medications that are available. No single NSAID is best for everyone with ankylosing spondylitis. You may use one medication for a two-week trial period before trying others. You can then judge which NSAID works best and use it for long-term treatment.
Another options is to take an NSAID in addition to a medication that can protect the stomach and duodenum. Anti-ulcer medications that help protect against NSAID damage include high dose histamine H2 blockers (famotidine, and others), proton-pump inhibitors (omeprazole, and others), or misoprostol.
Sulfasalazine — Sulfasalazine (Azulfidine®) is a disease-modifying antirheumatic drug, or DMARD, that may be given to slow or stop the progression of ankylosing spondylitis. It may be given along with NSAIDs. This drug provides some relief of arthritis symptoms but is not helpful if ankylosing spondylitis only affects the spine. (See "Patient information: Disease modifying antirheumatic drugs (DMARDs)".)
Anti-tumor necrosis factor therapy — A group of medicines known as anti-tumor necrosis factor agents (anti-TNF) are often effective in the treatment of ankylosing spondylitis. Examples of anti-TNF medications include: infliximab (Remicade®), etanercept (Enbrel®), and adalimumab (Humira®). People who do not respond to one anti-TNF treatment may respond to another.
At least 80 percent of people will respond to an anti-TNF agent. Improvement occurs within a few days to a few weeks of starting the drugs. However, these drugs are probably not very effective in stopping the progression of the disease.
Some physicians may also recommend a glucocorticoid injection into particularly painful or swollen joints, especially if there is only one or a two that are causing the most pain (see 'Glucocorticoids (steroids)' below. However, anti-TNF therapy may be needed if ankylosing spondylitis symptoms quickly return after injection.
Glucocorticoids (steroids) — In some cases, a glucocorticoid injection into the sacroiliac joint may help provide relief in patients who have sacroiliac pain that has not responded to other therapies. Injections may relieve pain in the sacroiliac joint for six months or more after injection.
In contrast, taking glucocorticoids by mouth is rarely necessary in ankylosing spondylitis treatment.
Surgery — Hip or spine surgery may be beneficial in selected patients with ankylosing spondylitis. Surgical procedures may include one or more of the following:
Total hip replacement — Insertion of an artificial hip may be recommended in patients with ankylosing spondylitis who have severe, persistent hip pain or severely limited mobility due to hip joint arthritis. (See "Patient information: Total hip replacement (arthroplasty)".)
Spinal surgery — Fusion of the bones in the cervical spine may be recommended for a small number of patients who develop dislocation of these bones. Such surgery may help prevent spinal cord damage.
Wedge osteotomy — Wedge osteotomy involves the removal of a wedge-shaped piece of bone from a vertebra, followed by realignment of the spine. The spine is then braced and allowed to heal in a better position. This type of procedure may be recommended for people who develop severe deformities of the neck that prevent them from turning their head in a forward direction.
PREVENTING ANKYLOSING SPONDYLITIS COMPLICATIONS
Because the severity and outcome of ankylosing spondylitis vary considerably among patients, treatment must be tailored to each particular patient. However, all patients can benefit from the following:
Medications that treat bone loss, such as alendronate (Fosamax®) and risedronate (Actonel®), may be recommended if you have already lost bone strength. (See "Patient information: Bone density testing" and "Patient information: Osteoporosis prevention and treatment".)
Your healthcare provider is the best source of information for questions and concerns related to your medical problem. Because no two people are exactly alike and recommendations can vary from one person to another, it is important to seek guidance from a provider who is familiar with your individual situation.
This discussion will be updated as needed every four months on our web site (www.uptodate.com/patients). Additional topics as well as selected discussions written for healthcare professionals are also available for those who would like more detailed information.
Some of the most pertinent include:
Patient Level Information:
Patient information: Disease modifying antirheumatic drugs (DMARDs)
Patient information: Arthritis and exercise
Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs)
Patient information: Sulfasalazine and the 5-aminosalicylates
Patient information: Total hip replacement (arthroplasty)
Patient information: Smoking cessation
Patient information: Calcium and vitamin D for bone health
Patient information: Bone density testing
Patient information: Osteoporosis prevention and treatment
Professional Level Information:
Clinical manifestations of ankylosing spondylitis in adults
Diagnosis and differential diagnosis of ankylosing spondylitis in adults
Diseases of the chest wall
Guidelines for cost-conscious use of anti-tumor necrosis factor alpha agents in ankylosing spondylitis in the United States
Pathogenesis of spondyloarthritis
Treatment and prognosis of ankylosing spondylitis in adults
Undifferentiated spondyloarthritis: Clinical manifestations, definition and diagnosis
A number of web sites have information about medical problems and treatments, although it can be difficult to know which sites are reputable. Information provided by the National Institutes of Health, national medical societies and some other well-established organizations are often reliable sources of information, although the frequency with which they are updated is variable.
(www.nlm.nih.gov/medlineplus/healthtopics.html)
(301) 496-8188
(www.nih.gov/niams/)
(404) 633-3777
(www.rheumatology.org)
(800) 283-7800
(www.arthritis.org)
[1-5]
| References |
Top
|
UpToDate performs a continuous review of over 430 journals and other resources. Updates are added as important new information is published. The literature review for version 17.3 is current through September 2009; this topic was last changed on December 22, 2008. The next version of UpToDate (18.1) will be released in March 2010.
![]() |
Please wait |